{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:02:09Z","timestamp":1793829729610,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5301"],"award-info":[{"award-number":["KFS-5301"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_189285"],"award-info":[{"award-number":["310030_189285"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","award":["MD-PhD-4820-06-2019"],"award-info":[{"award-number":["MD-PhD-4820-06-2019"]}],"id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neo.2022.100812","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:30:43Z","timestamp":1654277443000},"page":"100812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-4650","authenticated-orcid":false,"given":"Irma","family":"Telarovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen S.M.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Unkelbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-9015","authenticated-orcid":false,"given":"Martin","family":"Pruschy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neo.2022.100812_bib0001","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"issue":"4","key":"10.1016\/j.neo.2022.100812_bib0002","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.neo.2022.100812_bib0003","article-title":"The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis","author":"Dai","year":"2022","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.neo.2022.100812_bib0004","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neo.2022.100812_bib0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"6","key":"10.1016\/j.neo.2022.100812_bib0008","article-title":"Assessing the spleen as an organ at risk in radiation therapy and its relationship with radiation-induced lymphopenia: A retrospective study and literature review","volume":"6","author":"Alexandru","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.neo.2022.100812_bib0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2020.04.054","article-title":"Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?","volume":"149","author":"Jin","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.neo.2022.100812_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.neo.2022.100812_bib0011","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2020.04.012","article-title":"Comparison of nodal target volume definition in breast cancer radiation therapy according to RTOG versus ESTRO atlases: a practical review from the TransAtlantic Radiation Oncology Network (TRONE)","volume":"107","author":"Loganadane","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0012","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","article-title":"NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer","volume":"109","author":"Hall","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neo.2022.100812_bib0013","series-title":"Abstract GS4-02: Regional Lymph Node Irradiation in Early Stage Breast Cancer: An EBCTCG Meta-Analysis of 13,000 Women in 14 Trials","first-page":"GS4","author":"Dodwell","year":"2019"},{"issue":"3","key":"10.1016\/j.neo.2022.100812_bib0014","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijrobp.2019.11.012","article-title":"Shifting the curtain\u2014can we make sense of the whole pelvis controversy?","volume":"106","author":"Koontz","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neo.2022.100812_bib0015","series-title":"Seminars in Radiation Oncology","article-title":"Anal cancer in the era of dose painted intensity modulated radiation therapy: Implications for regional nodal therapy","author":"Ladbury","year":"2019"},{"issue":"12","key":"10.1016\/j.neo.2022.100812_bib0016","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neo.2022.100812_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102297","article-title":"De-escalation of axillary irradiation for early breast cancer\u2013Has the time come?","volume":"101","author":"Senkus","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.neo.2022.100812_bib0018","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer","author":"Weiner","year":"2019"},{"issue":"6","key":"10.1016\/j.neo.2022.100812_bib0019","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/HP.0000000000000094","article-title":"Early-response biomarkers for assessment of radiation exposure in a mouse total-body irradiation model","volume":"106","author":"Ossetrova","year":"2014","journal-title":"Health Phys"},{"issue":"1-4","key":"10.1016\/j.neo.2022.100812_bib0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rpd\/ncu127","article-title":"Further biodosimetry investigations using murine partial-body irradiation model","volume":"159","author":"Blakely","year":"2014","journal-title":"Radiat Prot Dosim"},{"issue":"6","key":"10.1016\/j.neo.2022.100812_bib0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/cmi.2010.45","article-title":"2-Gy whole-body irradiation significantly alters the balance of CD4+ CD25\u2212 T effector cells and CD4+ CD25+ Foxp3+ T regulatory cells in mice","volume":"7","author":"Qu","year":"2010","journal-title":"Cellular Molecular Immunol"},{"key":"10.1016\/j.neo.2022.100812_bib0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.neo.2022.100812_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2017.00229","article-title":"Barriers to radiation-induced in situ tumor vaccination","volume":"8","author":"Wennerberg","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.neo.2022.100812_bib0024","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/1878-0261.12658","article-title":"Radiotherapy\u2013immunotherapy combinations\u2013perspectives and challenges","volume":"14","author":"Mondini","year":"2020","journal-title":"Molecular Oncology"},{"issue":"3","key":"10.1016\/j.neo.2022.100812_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.radonc.2017.11.016","article-title":"ESTRO ACROP: Technology for precision small animal radiotherapy research: Optimal use and challenges","volume":"126","author":"Verhaegen","year":"2018","journal-title":"Radiother Oncol"},{"issue":"22","key":"10.1016\/j.neo.2022.100812_bib0026","doi-asserted-by":"crossref","first-page":"22NT02","DOI":"10.1088\/1361-6560\/abbb75","article-title":"Probing spatiotemporal fractionation on the preclinical level","volume":"65","author":"Telarovic","year":"2020","journal-title":"Phys Med Biol"},{"issue":"1069","key":"10.1016\/j.neo.2022.100812_bib0027","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160485","article-title":"Modelling responses to spatially fractionated radiation fields using preclinical image-guided radiotherapy","volume":"90","author":"Butterworth","year":"2017","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.neo.2022.100812_bib0028","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijrobp.2018.02.017","article-title":"Improved overall survival of mice by reducing lung side effects after high-precision heart irradiation using a small animal radiation research platform","volume":"101","author":"Sievert","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.neo.2022.100812_bib0029","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ijrobp.2018.12.010","article-title":"Preclinical evaluation of dose-volume effects and lung toxicity occurring in and out-of-field","volume":"103","author":"Ghita","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.neo.2022.100812_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.radonc.2013.10.003","article-title":"Development and validation of a treatment planning system for small animal radiotherapy: SmART-Plan","volume":"109","author":"van Hoof","year":"2013","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.neo.2022.100812_bib0031","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat Med"},{"issue":"1-2","key":"10.1016\/j.neo.2022.100812_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.12.025","article-title":"Use of the \u03b3-H2AX assay to monitor DNA damage and repair in translational cancer research","volume":"327","author":"Ivashkevich","year":"2012","journal-title":"Cancer Lett"},{"issue":"17","key":"10.1016\/j.neo.2022.100812_bib0033","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti\u2013CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0034","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: analysis of 3 phase 1\/2 trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neo.2022.100812_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-sparing radiotherapy: the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.neo.2022.100812_bib0036","series-title":"Computational and Experimental T Cell Immunology","first-page":"151","article-title":"Experimental and mathematical approaches to quantify recirculation kinetics of lymphocytes. Mathematical","author":"Ganusov","year":"2021"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0037","doi-asserted-by":"crossref","first-page":"e27357","DOI":"10.4161\/onci.27357","article-title":"Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7\/IL-15 response among high-grade glioma patients treated with radiation and temozolomide","volume":"3","author":"Ellsworth","year":"2014","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0038","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/09553002.2010.518208","article-title":"Different radiosensitivity of CD4+ CD25+ regulatory T cells and effector T cells to low dose gamma irradiation in vitro","volume":"87","author":"Cao","year":"2011","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0039","first-page":"1","article-title":"Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells","volume":"21","author":"Beauford","year":"2020","journal-title":"BMC immunology"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0040","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/s41598-021-81058-1","article-title":"Comparison of DNA repair and radiosensitivity of different blood cell populations","volume":"11","author":"Heylmann","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.neo.2022.100812_bib0041","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbcan.2014.04.009","article-title":"Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells","volume":"1846","author":"Heylmann","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100812_bib0042","doi-asserted-by":"crossref","first-page":"eabc7609","DOI":"10.1126\/sciadv.abc7609","article-title":"Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy","volume":"7","author":"Cheng","year":"2021","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.neo.2022.100812_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000867","article-title":"Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy","volume":"8","author":"Buchwald","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"20","key":"10.1016\/j.neo.2022.100812_bib0044","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1158\/1078-0432.CCR-17-3427","article-title":"Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy","volume":"24","author":"Marciscano","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2022.100812_bib0045","first-page":"1","article-title":"Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC","author":"O'Melia","year":"2021","journal-title":"Cancer Immunol, Immunotherapy"},{"issue":"5","key":"10.1016\/j.neo.2022.100812_bib0046","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.ijrobp.2020.12.004","article-title":"Effect of interleukin-7 on radiation-induced lymphopenia and its antitumor effects in a mouse model","volume":"109","author":"Byun","year":"2021","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"issue":"4","key":"10.1016\/j.neo.2022.100812_bib0047","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41422-018-0011-0","article-title":"A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy","volume":"28","author":"Du","year":"2018","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.neo.2022.100812_bib0048","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-18-0762","article-title":"Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.neo.2022.100812_bib0049","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/1078-0432.CCR-18-2509","article-title":"Lost in translation: deciphering the mechanism of action of anti-human CTLA-4","volume":"25","author":"Quezada","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:12:08Z","timestamp":1761484328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":49,"alternative-id":["S1476558622000392"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100812","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100812"}}